Skip to main content

Table 1 Baseline characteristics of patients who completed the Dutch SOSGOG2.0 questionnaire

From: Translation and validation of the Dutch Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) to evaluate health-related quality of life in patients with symptomatic spinal metastases

No. patients

147

Age in years, mean (SD)

65.6 (10.4)

Sex, female, n (%)

71 (48.3)

Primary tumor, n (%)

 Breast

49 (33.3)

 Prostate

36 (24.5)

 Lung

25 (17.0)

 Multiple myeloma

17 (11.6)

 Other

20 (13.6)

 Time since diagnosis of primary tumor in months, median (IQR)a

26.2 (15.7–67.9)

Location of spinal metastasis, n (%)b,c

 Cervical

23 (15.6)

 Thoracic

80 (54.4)

 Lumbar

70 (47.6)

 Sacral

19 (12.9)

Treatment of spinal metastasis, n (%)

 No treatment

2 (1.4)

 Radiotherapy only

85 (57.8)

 Surgery only

15 (10.2)

 Radiotherapy and surgery

45 (30.6)

 Time since start of treatment in months, median (IQR)

10.5 (4.3–16.8)

  1. Abbbreviations: IQR Interquartile range, No Number, SD Standard deviation
  2. aInformation not available from 24 (16.3%) patients
  3. bInformation not available from 6 (4.1%) patients, or patient received no treatment
  4. cPercentages do not add up to 100% as patients could have more than one location